LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001904.4:c.59C>T
CTNNB1
· NP_001895.1:p.(Ala20Val)
· NM_001904.4
GRCh37: chr3:41266062 C>T
·
GRCh38: chr3:41224571 C>T
Gene:
CTNNB1
Transcript:
NM_001904.4
Final call
Likely Benign
PM2 moderate
BP4 supporting
BP5 supporting
Variant details
Gene
CTNNB1
Transcript
NM_001904.4
Protein
NP_001895.1:p.(Ala20Val)
gnomAD AF
2.4787724127503096e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Likely Benign: PM2 moderate is insufficient by itself to satisfy a generic pathogenic combination.
2
Likely Benign: BP4 supporting is met by REVEL 0.085, below the 0.29 benign-prediction threshold.
3
Likely Benign: BP5 supporting is met because the tumor also carried several inactivating APC mutations.
Final determination:
Under the generic ACMG/AMP 2015 fallback, two Supporting benign criteria (BP4 and BP5) yield Likely Benign, while PM2 Moderate does not independently satisfy a pathogenic rule.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not met | Not met: p.Ala20Val is classified as uncertain significance in ClinVar, and available tumor reports do not establish a pathogenic germline amino-acid change. |
clinvar
PMID:33535453
|
| PS2 | Not assessed | Not assessed: no report documents confirmed maternity and paternity, a de novo germline event, and absence of family history for this variant. |
PMID:21901162
PMID:39202333
|
| PS3 | Not met | Not met: available evidence is computational or tumor-observational, with no validated in vitro or in vivo assay demonstrating a damaging effect for p.Ala20Val. |
PMID:39202333
PMID:32365560
PMID:33535453
PMID:21901162
|
| PS4 | Not assessed | Not assessed: exact-variant reports provide somatic tumor observations but no affected-versus-control counts or odds ratio with confidence interval. |
PMID:21901162
PMID:33535453
PMID:39202333
|
| PM1 | Not met | Not met: residue 20 is reported outside critical CTNNB1 sites, and Cancer Hotspots found no statistically significant hotspot. |
PMID:21901162
PMID:39202333
hotspots
|
| PM2 | Met | Met at Moderate: gnomAD v4.1 all-comers AF is 2.47877e-06 from 4/1,613,702 alleles, below the 0.0001 PM2 cutoff, with zero homozygotes. |
gnomad_v4
gnomad_v2
PMID:25741868
|
| PM3 | N/A | Not applicable: CTNNB1-related disease is autosomal dominant in this case, whereas PM3 is restricted to recessive disorders with a pathogenic variant confirmed in trans. |
PMID:21901162
PMID:33535453
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not met | Not met: p.Ala20Thr is a same-residue comparator, but the report does not establish it as pathogenic under ACMG/AMP. |
PMID:32365560
PMID:21901162
|
| PM6 | Not assessed | Not assessed: no proband-level report describes this variant as assumed de novo without confirmed parental testing. |
PMID:21901162
PMID:39202333
|
| PP1 | Not assessed | Not assessed: zero documented affected relatives with genotype and phenotype data are available for segregation analysis. |
PMID:21901162
PMID:39202333
|
| PP2 | Not assessed | Not assessed: no supplied gene-wide evidence establishes both low benign missense variation and missense as a common CTNNB1 disease mechanism. |
|
| PP3 | Not met | Not met: REVEL 0.085 is below the >=0.644 PP3 supporting threshold for this missense variant. |
revel
|
| PP4 | Not assessed | Not assessed: available reports describe somatic tumors, including one with inactivating APC mutations, not a highly specific germline CTNNB1 phenotype. |
PMID:21901162
PMID:32365560
PMID:33535453
|
| PP5 | Not met | Not met: ClinVar shows two ordinary laboratory Uncertain-significance submissions and zero expert-panel classifications for the exact variant. |
clinvar
|
| BA1 | Not assessed | Not assessed: gnomAD v4.1 total AF is 2.47877e-06, but the required grpmax FAF is unavailable and cannot be replaced by a popmax point estimate. |
gnomad_v4
clinvar
PMID:25741868
|
| BS1 | Not assessed | Not assessed: gnomAD v4.1 total AF is 2.47877e-06, but grpmax FAF is unavailable and no disorder-specific maximum credible frequency calculation is provided. |
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD reports zero homozygotes but does not document a specific healthy adult carrier with genotype, age, and phenotype. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS3 | Not met | Not met: no validated in vitro or in vivo assay shows that CTNNB1 p.Ala20Val has no damaging effect on protein function or splicing. |
PMID:39202333
PMID:32365560
PMID:33535453
PMID:21901162
|
| BS4 | Not assessed | Not assessed: no affected relatives have documented genotype and phenotype results showing that the variant fails to segregate. |
PMID:21901162
PMID:39202333
|
| BP1 | Not assessed | Not assessed: supplied extracts show both truncating and missense CTNNB1 disease observations but do not establish that disease is primarily truncating. |
|
| BP2 | Not assessed | Not assessed: no germline paired pathogenic variant or phase result is reported, so neither the BP2 trans nor cis condition can be evaluated. |
PMID:21901162
PMID:33535453
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Met | Met, supporting: REVEL 0.085 is below the <=0.29 BP4 threshold for this missense variant. |
revel
|
| BP5 | Met | Met, Supporting: the exact p.A20V colorectal tumor also carried several inactivating APC mutations, an alternate molecular basis for disease. |
PMID:21901162
|
| BP6 | Not met | Not met: no qualifying reputable benign report is available; ClinVar contains only two ordinary laboratory Uncertain-significance submissions and no expert-panel submission. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a missense variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.